Liwei Wang

2.3k total citations · 1 hit paper
43 papers, 1.3k citations indexed

About

Liwei Wang is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Liwei Wang has authored 43 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 13 papers in Oncology and 11 papers in Cancer Research. Recurrent topics in Liwei Wang's work include Pancreatic and Hepatic Oncology Research (9 papers), Immune cells in cancer (7 papers) and MicroRNA in disease regulation (4 papers). Liwei Wang is often cited by papers focused on Pancreatic and Hepatic Oncology Research (9 papers), Immune cells in cancer (7 papers) and MicroRNA in disease regulation (4 papers). Liwei Wang collaborates with scholars based in China, United States and Sweden. Liwei Wang's co-authors include Jiao Feng, Jiujie Cui, Cuncun Yuan, Hai Hu, Zhen Guo, Weihua Jiang, Ziliang Jin, Lei Wang, Ting Han and Weiwei Yang and has published in prestigious journals such as Nature Communications, The Journal of Cell Biology and PLoS ONE.

In The Last Decade

Liwei Wang

40 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Tumor cell-intrinsic epigenetic dysregulation shapes cancer-associated fibroblasts heterogeneity to metabolically support pancreatic cancer

2024 91 citations Ningning Niu, Xuqing Shen et al. Cancer Cell profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Liwei Wang China	16	790	506	320	250	178	43	1.3k
Fangfang Liu China	24	761 1.0×	471 0.9×	350 1.1×	170 0.7×	141 0.8×	73	1.4k
Toshiyuki Tsunoda Japan	23	843 1.1×	333 0.7×	328 1.0×	149 0.6×	102 0.6×	77	1.3k
Barbara Breznik Slovenia	20	480 0.6×	336 0.7×	358 1.1×	261 1.0×	70 0.4×	46	1.3k
Jia Yu United States	20	930 1.2×	270 0.5×	556 1.7×	182 0.7×	138 0.8×	55	1.5k
Yongxin Zou China	21	1.2k 1.5×	363 0.7×	269 0.8×	184 0.7×	81 0.5×	54	1.5k
Jennifer Yeh United States	16	762 1.0×	211 0.4×	369 1.2×	219 0.9×	104 0.6×	34	1.3k
Pan Tong China	18	608 0.8×	253 0.5×	326 1.0×	132 0.5×	98 0.6×	48	1.1k
Eric Lau United States	18	1.0k 1.3×	289 0.6×	253 0.8×	146 0.6×	292 1.6×	24	1.3k
Xiaojun Zha China	20	1.0k 1.3×	582 1.2×	208 0.7×	151 0.6×	71 0.4×	53	1.6k
Junchen Liu China	23	686 0.9×	207 0.4×	253 0.8×	142 0.6×	97 0.5×	53	1.2k

Countries citing papers authored by Liwei Wang

Since Specialization

Citations

This map shows the geographic impact of Liwei Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liwei Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liwei Wang more than expected).

Fields of papers citing papers by Liwei Wang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Liwei Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liwei Wang. The network helps show where Liwei Wang may publish in the future.

Co-authorship network of co-authors of Liwei Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Liwei Wang. A scholar is included among the top collaborators of Liwei Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Liwei Wang. Liwei Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zheng, Boyang, et al.. (2025). The molecular interplay between the gut microbiome and circadian rhythms: an integrated review. Frontiers in Microbiology. 16. 1712516–1712516.

Xu, Haiyan, Yang Sun, Jingyu Ma, et al.. (2025). CREB3L1 facilitates pancreatic tumor progression and reprograms intratumoral tumor-associated macrophages to shape an immunotherapy-resistance microenvironment. Journal for ImmunoTherapy of Cancer. 13(1). e010029–e010029. 1 indexed citations

Huang, Yaqin, Jiazhong Shi, Xiaozhou Zhou, et al.. (2025). XPC Deficiency Activate Cisplatin‐Mediated Autophagy in Bladder Cancer by Limiting Novel PHRF1‐Mediated Ubiquitination of the p53 Protein. Advanced Science. 13(5). e17563–e17563.

Niu, Ningning, Xuqing Shen, Yueyue Chen, et al.. (2024). Tumor cell-intrinsic epigenetic dysregulation shapes cancer-associated fibroblasts heterogeneity to metabolically support pancreatic cancer. Cancer Cell. 42(5). 869–884.e9. 91 indexed citations breakdown →

Cao, Ting, Shuangyang Zhang, Qian Chen, et al.. (2023). Long non-coding RNAs in schizophrenia: Genetic variations, treatment markers and potential targeted signaling pathways. Schizophrenia Research. 260. 12–22. 7 indexed citations

Wu, Xiuqi, et al.. (2023). The role of innate immune cells as modulators of the tumor microenvironment in the metastasis and treatment of pancreatic cancer. 2(1). 3 indexed citations

Wang, Liwei, et al.. (2023). KATP channels contribute to NK cell cytotoxicity. Biophysical Journal. 122(3). 523a–524a. 1 indexed citations

Ge, Weiyu, Yue Ming, Tianhao Zhou, et al.. (2023). PLA2G2A+ cancer-associated fibroblasts mediate pancreatic cancer immune escape via impeding antitumor immune response of CD8+ cytotoxic T cells. Cancer Letters. 558. 216095–216095. 44 indexed citations

Li, Shumin, Yue Ming, Haiyan Xu, et al.. (2023). Chemotherapeutic drugs-induced pyroptosis mediated by gasdermin E promotes the progression and chemoresistance of pancreatic cancer. Cancer Letters. 564. 216206–216206. 43 indexed citations

10.

Ge, Weiyu, Tiebo Mao, Xiaofei Zhang, et al.. (2022). Prediction of Survival and Tumor Microenvironment Infiltration Based on Pyroptosis-Related lncRNAs in Pancreatic Cancer. Disease Markers. 2022. 1–22. 10 indexed citations

11.

Xia, Qing, Jing Jia, Chupeng Hu, et al.. (2021). Tumor-associated macrophages promote PD-L1 expression in tumor cells by regulating PKM2 nuclear translocation in pancreatic ductal adenocarcinoma. Oncogene. 41(6). 865–877. 66 indexed citations

12.

Zhang, Xiao, Xiaofei Zhang, Tiebo Mao, et al.. (2021). CSE1L, as a novel prognostic marker, promotes pancreatic cancer proliferation by regulating the AKT/mTOR signaling pathway. Journal of Cancer. 12(10). 2797–2806. 10 indexed citations

13.

Yang, Xuguang, Yun Lu, Junjie Hang, et al.. (2020). Lactate-Modulated Immunosuppression of Myeloid-Derived Suppressor Cells Contributes to the Radioresistance of Pancreatic Cancer. Cancer Immunology Research. 8(11). 1440–1451. 183 indexed citations

14.

Wang, Liwei, Zhiqiang Zhou, Ronggai Li, et al.. (2020). Mapping QTL for flowering time-related traits under three plant densities in maize. The Crop Journal. 9(2). 372–379. 6 indexed citations

15.

Han, Ting, Meng Zhuo, Cuncun Yuan, et al.. (2020). Coordinated silencing of the Sp1-mediated long noncoding RNA MEG3 by EZH2 and HDAC3 as a prognostic factor in pancreatic ductal adenocarcinoma. Cancer Biology and Medicine. 17(4). 953–969. 21 indexed citations

16.

Cui, Jiujie, Zhuqing Zhou, Haiyan Yang, et al.. (2019). MST1 Suppresses Pancreatic Cancer Progression via ROS-Induced Pyroptosis. Molecular Cancer Research. 17(6). 1316–1325. 101 indexed citations

17.

Wang, Yu, Jiujie Cui, & Liwei Wang. (2019). Patient-derived xenografts: a valuable platform for clinical and preclinical research in pancreatic cancer. Chinese Clinical Oncology. 8(2). 17–17. 9 indexed citations

18.

Liang, Ji, Yajuan Zhang, Yan Xia, et al.. (2016). PKM2 dephosphorylation by Cdc25A promotes the Warburg effect and tumorigenesis. Nature Communications. 7(1). 12431–12431. 142 indexed citations

19.

Song, Weifeng, Lei Wang, Liwei Wang, & Qi Li. (2015). Interplay of miR-21 and FoxO1 modulates growth of pancreatic ductal adenocarcinoma. Tumor Biology. 36(6). 4741–4745. 14 indexed citations

20.

Su, Zhen-Zhu, Lijuan Mao, Na Li, et al.. (2013). Evidence for Biotrophic Lifestyle and Biocontrol Potential of Dark Septate Endophyte Harpophora oryzae to Rice Blast Disease. PLoS ONE. 8(4). e61332–e61332. 82 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact